TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

Brigimadlin versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety, and Translational Data from Brightline-1, a Randomized Phase II/III Trial.

Patrick Schöffski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.